20 Stocks Insiders Were Buying In Q1 2025

9. Zomedica Corp. (OTCQB:ZOMDF)

Market Cap: $56.84 million

Number of insiders buying: 8

Zomedica is a veterinary health company based in Ann Arbor, Michigan. The company specializes in diagnostic and therapeutic products for companion animals, offering solutions like TRUFORMA and TRUVIEW diagnostic platforms, along with PulseVet and Assisi Loop devices for pain and inflammation treatment. Zomedica also works with Celsee, Inc. and Seraph Biosciences, Inc. to develop advanced diagnostic and pathogen detection technologies. It is also one of the 15 cheapest stocks insiders are purchasing in March.

For the full year 2024, Zomedica reported revenue of $27.3 million, up from $25.2 million in 2023. Operating expenses reached $70.1 million, reflecting a full year of costs associated with Qorvo Biotechnologies, compared to $60.6 million the previous year. Research and development expenses increased to $7.3 million from $5.8 million in 2023, while the net loss widened to $47.0 million, compared to a loss of $34.5 million in 2023.

In March, eight insiders, including the company’s CEO, and COO, acquired a total of around $375,385 worth of Zomedica shares at an average price of $0.07 per share. Currently, the stock trades at $0.054 per share, having dropped 55% year-to-date, and 61.43% over the past 12 months.

According to MarketBeat, one analyst rates Zomedica stock as a “Moderate Buy” with a price target of $0.25 per share. The average price target suggests a 362.96% upside from the latest price.